<生产厂家价格>

匹美西林

匹美西林用途

Pivmecillinam (FL-1039) 是mecillinam的前体化合物,广谱抗生素。

匹美西林名称

[ CAS 号 ]:
32886-97-8

[ 中文名 ]:
匹美西林

[ 英文名 ]:
PIVMECILLINAM

[中文别名 ]:

氮卓脒青霉素双酯

[英文别名 ]:

Melysin
PIVMECILLINAM
Pivamdinocillin
AMDINOCILLIN PIVOXIL
Coactabs

匹美西林生物活性

[ 描述 ]:

Pivmecillinam (FL-1039) 是mecillinam的前体化合物,广谱抗生素。

[ 相关类别 ]:

信号通路 >> 抗感染 >> 细菌

研究领域 >> 感染

[参考文献]

[1]. Nicolle LE. Pivmecillinam in the treatment of urinary tract infections. J Antimicrob Chemother. 2000 Aug;46 Suppl A:35-39.

[2]. Graninger W. Pivmecillinam--therapy of choice for lower urinary tract infection. Int J Antimicrob Agents. 2003 Oct;22 Suppl 2:73-8.

[3]. Holme E, et al. Carnitine deficiency induced by pivampicillin and pivmecillinam therapy. Lancet. 1989 Aug 26;2(8661):469-73.

[相关活性小分子]

匹美西林物理化学性质

[ 密度 ]:
1.3±0.1 g/cm3

[ 沸点 ]:
581.0±60.0 °C at 760 mmHg

[ 熔点 ]:
118-119ºC

[ 分子式 ]:
C₂₁H₃₃N₃O₅S

[ 分子量 ]:
439.569

[ 闪点 ]:
305.2±32.9 °C

[ 精确质量 ]:
439.214081

[ PSA ]:
113.81000

[ LogP ]:
2.97

[ 蒸汽压 ]:
0.0±1.6 mmHg at 25°C

[ 折射率 ]:
1.604

[ 储存条件 ]:
2-8℃

匹美西林MSDS

详细MSDS(安全技术说明书)

匹美西林安全信息

[ 危害码 (欧洲) ]:
Xi

[ 风险声明 (欧洲) ]:
36/37/38

[ 安全声明 (欧洲) ]:
26-37/39

[ 危险品运输编码 ]:
NONH for all modes of transport

[ RTECS号 ]:
XI0185000

匹美西林文献

Use of antibiotics in nursing homes--surveillance with different methods.

Tidsskr. Nor. Laegeforen. 133(19) , 2052-6, (2013)

Residents in nursing homes have a heightened risk of developing infections that should be treated with antibiotics. Inappropriate use of antibiotics may generate drug-related problems and increase res...

New media for the semiselective isolation and enumeration of Xanthomonas campestris pv. mangiferaeindicae, the causal agent of mango bacterial black spot.

J. Appl. Microbiol. 99(4) , 803-15, (2005)

Mango bacterial black spot, caused by Xanthomonas campestris pv. mangiferaeindicae, is a potentially severe disease in several tropical and subtropical areas. Data describing the life cycle of the pat...

Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli.

Antimicrob. Agents Chemother. 54 , 4006-8, (2010)

An increase in extended-spectrum-beta-lactamase (ESBL)-producing Escherichia coli has been observed in outpatient settings. Consequently, 100 ESBL-positive E. coli isolates from ambulatory patients wi...

更多文献